Boarding Ring Glasses Versus Placebo Glasses or Not Glasses in the Treatment of Vestibular Neuritis (NEVRING)

Regional University Hospital Center (CHRU)

Status: Enrolling

Conditions: Vestibular Neuritis

Treatments: Diagnostic Test: Caloric test; Diagnostic Test: Angle of deviation at Fukuda; Other: EHTEV questionnaire; Other: EEV questionnaire; Diagnostic Test: Alexander's degree of nystagmus; Diagnostic Test: Measurement of the speed of Nystagmus; Other: anxiety VAS

Study type: Interventional

Funder types: Other

Identifiers

NCT04678167

29BRC20.0040

Details and patient eligibility

About

Vestibular neuritis is a brutal and continuous dizzying syndrome of peripheral (vestibular) origin without cochlear or other associated involvement. Specifically, vestibular neuritis is inflammation of the nerve that innervates the vestibular canals (the inner ear). It is characterized by the sudden onset of intense and prolonged vertigo accompanied by postural imbalance, nausea and vomiting, without hearing impairment or other neurological symptoms. Vestibular neuritis is the second cause of peripheral vertigo after benign paroxysmal positional vertigo. It represents approximately 7% of patients consulting for vertigo. The purpose of this study is to evaluate if wearing Boarding Ring glasses can be accelerated vestibular compensation.

Enrollment: 51 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• adult patients,
• patient with vestibular neuritis defined by appearance of continuous rotating vertigo with nausea
• patient with spontaneous horizonto-rotating nystagmus beating towards the healthy ear
• patient with a postural deviation towards the affected ear;
• vestibular hyporeflexia measured at the caloric tests greater than 25%
• patient who has given free, enlighten and written consent

Exclusion criteria

• patient with a history of vertigo of vestibular origin or with vertigo developing for more than 4 days
• patient with associated hearing loss or tinnitus
• patient with an motor ocular abnormality of central origin
• patient refusal or inability to consent

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

51 participants in 3 patient groups, including a placebo group

Boarding ring glasses

Experimental group

Description:

Realization of the following examinations WITH Boarding ring glasses : * caloric tests, * measurement of the speed of Nystagmus, * angle of deviation in Fukuda, * Alexander's degree of nystagmus, * EHTEV and EEV questionnaires, * anxiety VAS

Treatment:

Other: EHTEV questionnaire

Diagnostic Test: Angle of deviation at Fukuda

Diagnostic Test: Alexander's degree of nystagmus

Other: anxiety VAS

Diagnostic Test: Measurement of the speed of Nystagmus

Other: EEV questionnaire

Diagnostic Test: Caloric test

Placebo glasses

Placebo Comparator group

Description:

Realization of the following examinations WITH Placebo glasses : * caloric tests, * measurement of the speed of Nystagmus, * angle of deviation in Fukuda, * Alexander's degree of nystagmus, * EHTEV and EEV questionnaires, * anxiety VAS

Treatment:

Other: EHTEV questionnaire

Diagnostic Test: Angle of deviation at Fukuda

Diagnostic Test: Alexander's degree of nystagmus

Other: anxiety VAS

Diagnostic Test: Measurement of the speed of Nystagmus

Other: EEV questionnaire

Diagnostic Test: Caloric test

No glasses

Other group

Description:

Realization of the following examinations WITHOUT glasses : * caloric tests, * measurement of the speed of Nystagmus, * angle of deviation in Fukuda, * Alexander's degree of nystagmus, * EHTEV and EEV questionnaires, * anxiety VAS

Treatment:

Other: EHTEV questionnaire

Diagnostic Test: Angle of deviation at Fukuda

Diagnostic Test: Alexander's degree of nystagmus

Other: anxiety VAS

Diagnostic Test: Measurement of the speed of Nystagmus

Other: EEV questionnaire

Diagnostic Test: Caloric test